Skip to content

Effect and mechanism of repetitive transcranial magnetic stimulation in treating frozen gait in Parkinson's disease

Effect and mechanism of repetitive transcranial magnetic stimulation in treating frozen gait in Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096100
Enrollment
Unknown
Registered
2025-01-17
Start date
2025-01-17
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Experimental group:The rTMS of 10.0Hz was applied to the M1-DLPFC region of the dominant hemisphere of subjects in the true stimulation group with a stimulation intensity of 100% motor resting thresho
Control group:The coil is perpendicular to the surface of the skull, so it is an invalid stimulus, and the stimulation parameters, stimulation time, and stimulation frequency are the same as those of

Sponsors

Drum Tower Hospital, Affiliated Hospital of Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for Parkinson's disease in China (2016 edition); (2) Meet the diagnostic criteria for frozen gait; (3) If the subject is taking oral Parkinson's disease medication, he or she needs to have a stable drug regimen for at least 28 days, and the regimen should be kept unchanged during treatment and follow-up; (4) The age of the patient is between 40~75 years old; (5) Able to sign the informed consent form for the study.

Exclusion criteria

Exclusion criteria: 1.Pregnant woman; 2.Parkinson's syndrome (including traumatic, neoplastic, drug-induced, toxic, vascular and hydrocephalus, etc.) and Parkinson's syndrome; 3.With a history of epilepsy; 4.Patients with metal implants such as cardiac pacemakers and deep brain stimulation after treatment; 5.Patients with decompensated systemic disease; 6.CT or MRI showed calcification of striatum, lacunar infarction of striatum, hydrocephalus, and white matter abnormalities.

Design outcomes

Primary

MeasureTime frame
The improvement of FOG;Improvement on exercise-related scales in Parkinson's disease;

Secondary

MeasureTime frame
Improvement of fMRI structural and functional brain networks;

Countries

China

Contacts

Public ContactZhang Yang

Drum Tower Hospital, Affiliated Hospital of Medical School

zxy419@163.com+86 25 83106666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026